Dynamic Technology Lab Private Ltd Reduces Position in Phreesia, Inc. (NYSE:PHR)

Dynamic Technology Lab Private Ltd reduced its stake in Phreesia, Inc. (NYSE:PHR - Free Report) by 54.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,850 shares of the company's stock after selling 13,229 shares during the quarter. Dynamic Technology Lab Private Ltd's holdings in Phreesia were worth $273,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. State Street Corp boosted its holdings in shares of Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company's stock valued at $30,256,000 after acquiring an additional 88,517 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Phreesia by 10.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock valued at $12,415,000 after buying an additional 46,209 shares in the last quarter. Wesbanco Bank Inc. increased its position in shares of Phreesia by 76.9% during the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company's stock worth $1,157,000 after purchasing an additional 20,000 shares in the last quarter. Barclays PLC raised its position in shares of Phreesia by 83.6% in the third quarter. Barclays PLC now owns 94,929 shares of the company's stock valued at $2,163,000 after buying an additional 43,225 shares during the last quarter. Finally, Franklin Resources Inc. raised its holdings in Phreesia by 3.0% in the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock valued at $31,495,000 after acquiring an additional 42,973 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PHR has been the topic of several analyst reports. DA Davidson reduced their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a report on Monday. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 price objective on shares of Phreesia in a report on Thursday, March 13th. Piper Sandler reiterated an "overweight" rating and set a $33.00 target price (up from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Citigroup lifted their price objective on Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a research note on Friday, January 10th. Finally, Canaccord Genuity Group increased their target price on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, March 13th. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $31.33.

Insider Activity

In other news, COO Evan Roberts sold 3,519 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $30.06, for a total transaction of $105,781.14. Following the completion of the transaction, the chief operating officer now directly owns 741,197 shares of the company's stock, valued at approximately $22,280,381.82. This represents a 0.47 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Yvonne Hui sold 1,878 shares of the business's stock in a transaction on Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total transaction of $44,790.30. Following the sale, the insider now owns 28,449 shares in the company, valued at $678,508.65. The trade was a 6.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 168,791 shares of company stock valued at $4,700,424. Company insiders own 5.80% of the company's stock.

Phreesia Stock Performance

Shares of PHR traded down $0.13 during mid-day trading on Wednesday, hitting $23.84. 63,750 shares of the company's stock were exchanged, compared to its average volume of 472,117. The firm has a market capitalization of $1.40 billion, a P/E ratio of -16.21 and a beta of 0.82. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The business's 50 day moving average is $26.37 and its two-hundred day moving average is $24.28. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.